scholarly journals Treating type 2 Diabetes Mellitus in non-critical settings. Does choice of insulin regimen really matter?

2014 ◽  
Vol 30 (4) ◽  
Author(s):  
Tehseen Akhtar Syed
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Insulin Regimen

scholarly journals Patients with Type 2 Diabetes Mellitus failing on oral agents and starting once daily insulin regimen; a small randomized study investigating effects of adding vildagliptin

2014 ◽  
Vol 7 (1) ◽  
Author(s):  
Wendela Lucia de Ranitz-Greven ◽  
Joline Wilhelma Johanna Beulens ◽  
Lette Birgit Elisabeth Anne Hoeks ◽  
Gerdien Belle-van Meerkerk ◽  
Douwe Hedde Biesma ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Randomized Study ◽  
Insulin Regimen ◽  
Once Daily ◽  
Daily Insulin ◽  
Oral Agents

scholarly journals Review of basal-plus insulin regimen options for simpler insulin intensification in people with Type 2 diabetes mellitus

2017 ◽  
Vol 34 (9) ◽  
pp. 1193-1204 ◽  
Author(s):  
D. Raccah ◽  
D. Huet ◽  
A. Dib ◽  
F. Joseph ◽  
B. Landers ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Insulin Regimen ◽  
Insulin Intensification

scholarly journals Milk-induced hypertriglyceridaemia and acute pancreatitis after discontinuation of treatment for type 2 diabetes and hyperlipidaemia

2019 ◽  
Vol 12 (8) ◽  
pp. e231562
Author(s):  
Neel Gautam Jain ◽  
Anya Hargreaves
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Acute Pancreatitis ◽  
Type 2 Diabetes Mellitus ◽  
Insulin Regimen ◽  
Dairy Intake ◽  
Discontinuation Of Treatment ◽  
Life Threatening ◽  
The Impact

A 39-year-old man with a background of type 2 diabetes mellitus presented with extreme hypertriglyceridaemia (114.4 mmol/L) and acute pancreatitis, attributed to excessive dairy intake. At his peak, he was drinking up to 6 pints of full fat milk a day. He was treated with an insulin regimen and was counselled on the danger his diet posed to his health. He recovered well, but this case highlights the impact that dietary and lifestyle factors can have on health, sometimes with life-threatening results.

scholarly journals Therapeutic Efficacy of Mitiglinide Combined with Once Daily Insulin Glargine after Switching from Multiple Daily Insulin Regimen of Aspart Insulin and Glargine in Patients with Type 2 Diabetes Mellitus

2006 ◽  
Vol 53 (1) ◽  
pp. 67-72 ◽  
Author(s):  
Tomoaki YOSHIHARA ◽  
Naoki KUMASHIRO ◽  
Yoshie KANAZAWA ◽  
Tomoya MITA ◽  
Yuko SAKURAI ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Insulin Glargine ◽  
Therapeutic Efficacy ◽  
Insulin Regimen ◽  
Once Daily ◽  
Daily Insulin ◽  
Aspart Insulin

scholarly journals Efficacy and safety of treatment with human insulin analogues in daily management of insulin naive patients with type 2 diabetes mellitus: results of multicenter 52-week observational study A1chive

2012 ◽  
Vol 15 (4) ◽  
pp. 115-121
Author(s):  
Marina Vladimirovna Shestakova
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Glycemic Control ◽  
Observational Study ◽  
Human Insulin ◽  
Negative Influence ◽  
Insulin Analogues ◽  
Insulin Regimen

Modern insulin analogues allow safe improvement of glycemic control (not accompanied with increase in body mass or rate of severe hypoglycemic events) and its efficient maintenance during long period of time. In this paper we present results of multicenter 52-week prospective observational study A1chive (Russian cohort, n=9342), designed to assess safety and efficacy of treatment with human insulin analogues (Levemir?, NovoMix? 30 and NovoRapid? (Novo Nordisk) in daily management of insulin naive patients with type 2 diabetes mellitus. Prescription of human insulin analogues resulted in clinically and statistically significant improvement of glycemic control irrespective of initial insulin regimen. Therapy by various regimens (Levemir?, NovoMix? 30 or Levemir? + NovoRapid?) under conditions of daily clinical practice leads to marked improvement in glycemic control as measured by HbA1c (-2.9% in 12 month) with no evidence for negative influence on tolerability and short-term safety of the treatment. Furthermore, decrease in HbA1c levels was associated with pronounced and stable decrease in fasting and postprandial glucose levels (-5.0 mmol/L and -5.7 mmol/L, respectively). By the end of the follow-up all regimen groups reported improvement of QoL by treatment satisfaction criterion.

880-P: Insulin Regimen and Glycemic Control in People with Type 2 Diabetes Mellitus

Diabetes ◽  
2021 ◽  
Vol 70 (Supplement 1) ◽  
pp. 880-P
Author(s):  
AMAR ARUNACHALAM ◽  
RAJESH GARG
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Glycemic Control ◽  
Insulin Regimen

scholarly journals Effect of switching basal insulin regimen to degludec on quality of life in Japanese patients with type 1 and type 2 diabetes mellitus

2015 ◽  
Vol 1 (1) ◽  
Author(s):  
Morihiro Okada ◽  
Masae Okada ◽  
Jun Nishigami ◽  
Naoto Yamaaki ◽  
Kenji Furukawa ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Basal Insulin ◽  
Japanese Patients ◽  
Insulin Regimen
Sign in / Sign up

Export Citation Format

Share Document